Keyphrases
Triple-negative Breast Cancer
100%
Antibody-drug Conjugate
100%
Breaking Barriers
100%
Cleavable
25%
Linker
25%
Targeting Antibodies
25%
HER2-targeted Therapy
25%
Monoclonal Antibody
12%
Systemic Therapy
12%
Novel Class
12%
Advanced or Metastatic
12%
HER2-positive Breast Cancer
12%
Advanced Disease
12%
Recombinant Antibody
12%
Cancer Inpatients
12%
Cytotoxic Agents
12%
SN-38
12%
Conventional Chemotherapy
12%
Treatment Algorithm
12%
Surface Antigen
12%
Resistance Mechanisms
12%
Topoisomerase Inhibitors
12%
Diseases Therapeutic
12%
Therapeutic Landscapes
12%
Resistance Emergence
12%
Sacituzumab Govitecan
12%
Advanced Triple-negative Breast Cancer
12%
Hydrolysable
12%
Metastatic Triple-negative Breast Cancer
12%
TROP2
12%
Trophoblast Cell Surface Antigen 2
12%
Narrow Therapeutic Window
12%
Triple-negative Disease
12%
Unresectable Locally Advanced
12%
Medicine and Dentistry
Triple Negative Breast Cancer
100%
Antibody-Drug Conjugate
100%
Monoclonal Antibody
25%
Membrane Antigen
25%
Diseases
25%
Systemic Therapy
12%
Therapeutic Window
12%
SN-38
12%
Trophoblast
12%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
12%
Sacituzumab Govitecan
12%
Topoisomerase Inhibitor
12%
Cytotoxic Agent
12%
Immunology and Microbiology
Antibody Drug Conjugate
100%
Monoclonal Antibody
25%
Membrane Antigen
25%
Trophoblast
12%
Sacituzumab Govitecan
12%